David M. Knott’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.65M | Buy |
102,555
+2,900
| +3% | +$46.6K | 0.6% | 44 |
|
|
2021
Q2 | $1.38M | Hold |
99,655
| – | – | 0.49% | 47 |
|
|
2021
Q1 | $1.46M | Sell |
99,655
-2,000
| -2% | -$29.2K | 0.62% | 43 |
|
|
2020
Q4 | $1.77M | Buy |
101,655
+2,162
| +2% | +$37.6K | 0.8% | 33 |
|
|
2020
Q3 | $1.83M | Sell |
99,493
-5,073
| -5% | -$93.1K | 1.07% | 23 |
|
|
2020
Q2 | $1.87M | Buy |
104,566
+37,527
| +56% | +$670K | 1.02% | 26 |
|
|
2020
Q1 | $1.09M | Sell |
67,039
-8,675
| -11% | -$141K | 0.69% | 27 |
|
|
2019
Q4 | $1.36M | Buy |
75,714
+12,327
| +19% | +$222K | 0.55% | 33 |
|
|
2019
Q3 | $1.28M | Buy |
63,387
+1,000
| +2% | +$20.3K | 0.54% | 35 |
|
|
2019
Q2 | $1.38M | Buy |
62,387
+21,918
| +54% | +$484K | 0.58% | 31 |
|
|
2019
Q1 | $552K | Buy |
40,469
+100
| +0.2% | +$1.36K | 0.22% | 58 |
|
|
2018
Q4 | $365K | Hold |
40,369
| – | – | 0.17% | 60 |
|
|
2018
Q3 | $666K | Buy |
40,369
+49
| +0.1% | +$808 | 0.22% | 54 |
|
|
2018
Q2 | $564K | Hold |
40,320
| – | – | 0.21% | 61 |
|
|
2018
Q1 | $446K | Buy |
40,320
+2,000
| +5% | +$22.1K | 0.18% | 63 |
|
|
2017
Q4 | $337K | Buy |
38,320
+4,000
| +12% | +$35.2K | 0.13% | 71 |
|
|
2017
Q3 | $458K | Buy |
34,320
+12,000
| +54% | +$160K | 0.2% | 62 |
|
|
2017
Q2 | $320K | Buy |
+22,320
| New | +$320K | 0.13% | 58 |
|